CLINICAL TRIALS PROFILE FOR ICODEXTRIN
✉ Email this page to a colleague
All Clinical Trials for ICODEXTRIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00004987 ↗ | Treatment of Advanced AIDS Patients With Dextrin Sulfate | Unknown status | Steinhart Medical Associates | Phase 1 | 1999-10-01 | The purpose of this study is to look at the safety and effectiveness of dextrin sulfate in AIDS patients who have failed conventional anti-HIV treatment. |
NCT00119990 ↗ | Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis | Terminated | University of Aarhus | N/A | 2006-01-01 | During peritoneal dialysis, water is removed from the body. This sometimes occurs at rates of up to 500 ml/h. During shifts with dialysate with high glucose content, an increase in blood pressure has been described. The effect upon central hemodynamics is unknown. The researchers are investigating the effects of low and high glucose dialysate and icodextrin on cardiac output, stroke volume, pulse rate and blood pressure. The researchers have hypothesized that the effects seen are induced by vasopressin. |
NCT00369096 ↗ | Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina) | Completed | Infociencia S.L | Phase 2 | 2006-09-01 | The purpose of this study is to evaluate whether addition of bemiparin, once daily in icodextrin solution for peritoneal dialysis for 16 weeks, increases the peritoneal capacity for ultrafiltration and/or reduces creatinine transport in peritoneal dialysis patients presenting functional disorders related to ultrafiltration deficit and/or high transport. |
NCT00369096 ↗ | Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina) | Completed | Fundación Renal Iñigo Alvarez De Toledo | Phase 2 | 2006-09-01 | The purpose of this study is to evaluate whether addition of bemiparin, once daily in icodextrin solution for peritoneal dialysis for 16 weeks, increases the peritoneal capacity for ultrafiltration and/or reduces creatinine transport in peritoneal dialysis patients presenting functional disorders related to ultrafiltration deficit and/or high transport. |
NCT00397358 ↗ | Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients | Withdrawn | Baxter Healthcare Corporation | Phase 4 | 2006-11-01 | This is a Phase IV study evaluating triglyceride levels in peritoneal dialysis patients. |
NCT00725517 ↗ | Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange | Completed | Shanghai Jiao Tong University School of Medicine | Phase 4 | 2005-12-01 | The purpose of this study is to evaluate the efficacy and safety of a 7.5% Icodextrin peritoneal dialysis solution for once-daily long dwell exchange in patients undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD) in Chinese uremic patients.Patients were divided into Dianeal group or Extraneal group for long dwell time. Net ultrafiltration, small solute clearance and relationship between different transport group were used to evaluate efficacy of Icodextrin. Physical examination, vital signs and laboratory tests were used to evaluate safety of Icodextrin. |
NCT01044446 ↗ | Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis | Completed | Chinese University of Hong Kong | Phase 4 | 2010-01-01 | The objective of the present study is to evaluate the a prior hypothesis that treatment with icodextrin during acute peritonitis would improve the treatment outcomes of peritonitis complicating peritoneal dialysis. The safety and effectiveness of icodextrin for decreasing glucose exposure, extent and severity of peritonitis will be evaluated in the setting of acute peritonitis complicating peritoneal dialysis among patients who are not receiving icodextrin. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ICODEXTRIN
Condition Name
Clinical Trial Locations for ICODEXTRIN
Trials by Country
Clinical Trial Progress for ICODEXTRIN
Clinical Trial Phase
Clinical Trial Sponsors for ICODEXTRIN
Sponsor Name